STAT5A and cancer: As we have previously demonstrated the ability of HP1 and unphosphorylated STAT5A to suppress cancer growth without significantly affecting the expression levels of genes that control cell cycle and apoptosis16, we also hope to verify that our drug hits have the ability to suppress cancer growth in vivo without severe cytotoxic side effects.